ARES · Ares Management Corporation
AI read · Neutral
The AI's read
Ares is arranging a $2.2 billion direct loan to fund MedImpact’s acquisition of Medical Card System. It’s one of the largest private-credit deals this year. Shares are down about 2.2% since the news and RSI sits mid-range at 48.76. The market may be pricing concerns around second-lien exposure, an at-least eight percentage point spread, and fundraising pressure. We lean neutral. The transaction shows Ares’ origination scale but the financing terms and private-credit headwinds cut both ways.